BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Nov 11, 2013
Clinical News

Anti-CD40L Fab: Phase Ib started

BioCentury | Jan 2, 2012
Company News

Biogen Idec, UCB, ALS TDI deal

BioCentury | Jan 27, 2011
Distillery Therapeutics

Indication: Musculoskeletal disease

BioCentury | May 10, 2010
Clinical News

Anti-CD40L Fab: Phase I started

Items per page:
1 - 4 of 4